Network Members

BioCanRx is a Network of Centres of Excellence (NCE), and in our case it means that we are working to foster a Canadian network that develops cancer biotherapeutics, and uses rational and directed investments to accelerate the rate of that progress to the clinic.

 

While our network includes many partner organizations, our official network members are the academic institutions of the investigators whom we have funded directly, as outlined by the NCE Program.

 

Below you will find lists of our:

 

 

NETWORK MEMBERS

 

 

[Top]

 

CURRENTLY FUNDED INVESTIGATORS

 

John Babcook Vice-President, Biologics, Centre for Drug Research and Development
Adjunct Professor, Simon Fraser University
John Bell Scientific Director, BioCanRx
Senior Scientist, The Ottawa Hospital
Professor, uOttawa
Jonathan Bramson Professor, Pathology and Molecular Medicine, McMaster University
Director, Fraunhofer Project Centre for Biomedical Engineering and Advanced Manufacturing
Byram Bridle Assistant Professor, Pathobiology, Ontario Veterinary College, University of Guelph
Marcus Butler Clinician–Investigator, Cancer Clinical Research Unit, Princess Margaret Cancer Centre
Raja Ghosh Professor, Chemical Engineering, McMaster University
Jonathan Bramson Professor, Pathology and Molecular Medicine, McMaster University
Director, Fraunhofer Project Centre for Biomedical Engineering and Advanced Manufacturing
Naoto Hirano Senior Scientist, Princess Margaret Cancer Centre, University Health Network
Brian Lichty Associate Professor, Pathology and Molecular Medicine, McMaster University
BioCanRx funding
Andrea McCart Senior Scientist, Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network
Jason Moffat Associate Professor, Molecular Genetics, University of Toronto
Pamela Ohashi Senior Scientist, Princess Margaret Cancer Centre, University Health Network
Director, Immune Therapy Program, Ontario Cancer Institute
Christopher Paige Vice President, Research, University Health Network Senior Scientist, Princess Margaret Cancer Centre
Claude Perreault Principal Investigator, Institute for Research in Immunology and Cancer, Université de Montréal
Professor, Department of Medicine, Faculty of Medicine, Université de Montréal
Hematologist, Maisonneuve-Rosemont Hospital
Denis-Claude Roy Scientific Director, Centre de Recherche Hôpital Maisonneuve-Rosemont
Director, Cellular Therapy Laboratory
Professor, Université de Montréal
David Stojdl Senior Scientist, Apoptosis Research Centre, CHEO Research Institute
Associate Professor, Department of Pediatrics, University of Ottawa
Yonghong Wan Professor, Pathology and Molecular Medicine, McMaster University

 

[Top]

 

FOUNDING INVESTIGATORS

 

Harold Atkins Chair of BioCanRx Training Committee
Scientist, Ottawa Hospital Research Institute
Associate Professor, University of Ottawa
Attending Physician, Blood and Marrow Transplant Program, The Ottawa Hospital
Rebecca Auer Scientist, Ottawa Hospital Research Institute
Surgical oncologist, The Ottawa Hospital
Assistant Professor, Faculty of Medicine, uOttawa
John Babcook Adjunct Professor, Simon Fraser University
Vice President, Biologics, Centre for Drug Research and Development
John Bell Scientific Director, BioCanRx
Senior Scientist, Ottawa Hospital Research Institute
Professor, uOttawa
Neil Berinstein Director, Translational Research, Ontario Institute for Cancer Research
Affiliate Scientist, Sunnybrook Research Institute
Jonathan Bramson Professor, Pathology and Molecular Medicine, McMaster University
Director, Fraunhofer Project Centre for Biomedical
Engineering and Advanced Manufacturing
Byram Bridle Assistant Professor, Pathobiology, Ontario Veterinary College, University of Guelph
Tania Bubela Professor and Associate Dean, School of Public Health and School of Business, University of Alberta
Marcus Butler Clinician–Investigator, Cancer Clinical Research Unit, Princess Margaret Cancer Centre
Janet Dancey Director, Clinical Translational Research, NCIC Clinical Trials Group
Program Leader, High Impact Clinical Trials, Ontario Institute for Cancer Research
Professor, Oncology, Queen’s University
Gregory Dekaban Scientist, Robarts Research Institute
Co-Director, BioTherapeutics Research Group
Jean-Simon Diallo Scientist, Ottawa Hospital Research Institute
Assistant Professor, Biochemistry, Microbiology and Immunology, uOttawa
David Evans Professor and Vice Dean (Research), University of Alberta
Dean Fergusson Director and Senior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute
Professor, Medicine, Surgery, and Epidemiology and Community Medicine, uOttawa
Raja Ghosh Professor, Chemical Engineering, McMaster University
Carl Hansen Associate Professor, Physics and Astronomy, University of British Columbia
Naoto Hirano Scientist, Princess Margaret Cancer Centre, University Health Network
Robert Holt Head of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency
Professor, Molecular Biology and Biochemistry, Simon Fraser University
Professor, Medical Genetics, University of British Columbia
Derek Jonker Clinician–Investigator, The Ottawa Hospital
Associate Professor, Medical Oncology, uOttawa
Jonathan Kimmelman Associate Professor, Biomedical Ethics Unit, McGill University
Réjean Lapointe Associate Professor, Medicine, Université de Montréal
Director, Laboratory of Immuno-oncology, Centre de Recherche du Centre Hospitalier de l’Université de Montréal
David Latulippe Assistant Professor, Chemical Engineering, McMaster University
Brian Lichty Associate Professor, Pathology and Molecular Medicine, McMaster University
Douglas Mahoney Member, Genes Development and Health, Alberta Children’s Hospital Research Institute
Assistant Professor, Department of Microbiology, Immunology & Infectious Diseases
Tak Mak Senior Scientist, Princess Margaret Cancer Centre, University Health Network
Christopher McCabe Research Director, Emergency Medicine, University of Alberta Hospital
Andrea McCart Senior Scientist, Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network
Jeffrey Medin Senior Scientist, University Health Network
Nicole Mittmann Associate Scientist, Sunnybrook Research Institute
Executive Director, Health Outcomes and PharmacoEconomics (HOPE) Research Centre
Jason Moffat Associate Professor, Molecular Genetics, University of Toronto
Brad Nelson Director and Distinguished Scientist, Deeley Research Centre, BC Cancer Agency
Professor, Biochemistry and Microbiology, University of Victoria
Professor, Medical Genetics, University of British Columbia
Pamela Ohashi Senior Scientist, Princess Margaret Cancer Centre, University Health Network
Director, Immune Therapy Program, Ontario Cancer Institute
Christopher Paige Vice President, Research, University Health Network
Senior Scientist, Princess Margaret Cancer Centre
Claude Perreault Professor, Medicine, Université de Montréal
Immunobiology Research Unit, Institute for Research in Immunology and Cancer
Hematologist, Hôpital Maisonneuve-Rosemont
Denis-Claude Roy Scientific Director, Centre de Recherche Hôpital Maisonneuve-Rosemont
Director, Cellular Therapy Laboratory
Professor, Université de Montréal
Sachdev Sidhu Professor, Donnelly Centre for Cellular and Biomolecular Research, Molecular Genetics, University of Toronto
David Stojdl Senior Scientist, Apoptosis Research Centre, CHEO Research Institute
Associate Professor, Department of Pediatrics, University of Ottawa
Simon Turcotte Principal Scientist, Centre de Recherche du Centre Hospitalier de l’Université de Montréal
Assistant Professor, Surgery, Université de Montréal
Physician, Hepatopancreatobiliary and Liver Transplantation Division, Centre Hospitalier de l’Université de Montréal
Yonghong Wan Professor, Pathology and Molecular Medicine, McMaster University
J. Paul Woods Professor, Internal Medicine Oncology, Ontario Veterinary College, University of Guelph
Martin Yaffe Senior Scientist, Sunnybrook Research Institute
Professor, Medical Imaging and Medical Biophysics, University of Toronto